Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2005
11/23/2005CN1698599A Bilobalide injection and preparation method thereof
11/23/2005CN1698598A Tanshinone IIA sodium sulfonate transfusion liquid, its preparation method and photophobic outer package
11/23/2005CN1698597A Tanshinone IIA drop pills, its preparation method and application
11/23/2005CN1698596A Stable medicament composition containing propylgallate for injection
11/23/2005CN1698595A Tiopronin injection and preparation method thereof
11/23/2005CN1698594A Tiopronin slow releasing preparation
11/23/2005CN1698593A Preparation method for increasing dissolution of sofalcone
11/23/2005CN1698592A Medicament composition for treating extracranial noumenal tumour
11/23/2005CN1698591A Ginger phenols extract microcapsule and preparation method thereof
11/23/2005CN1698590A Aarin preparation for injection and preparing process thereof
11/23/2005CN1698589A Aarin oral cavity disintegrating tablet and preparation method thereof
11/23/2005CN1698588A Popofol oral anesthesia agent and preparation method thereof
11/23/2005CN1698587A Total diterpene phenol originated from rosemary, its preparation method and use
11/23/2005CN1698586A Otacosane alcohol extract micro-encapsulation powder and preparation method thereof
11/23/2005CN1228450C Antigenic preparations
11/23/2005CN1228449C Ganoderma mycellium antitumour water soluble neteropolysaccharide and its preparation method and use
11/23/2005CN1228343C Substance having steroid-like structure, process for production thereof and antitumor agents containing same
11/23/2005CN1228341C Process for producing camptothecin
11/23/2005CN1228337C Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
11/23/2005CN1228335C Crystal choline ascorbate
11/23/2005CN1228334C Anti-tumour effective constituent cherimoya essence preparation method
11/23/2005CN1228330C Imidazole derivatives or their salts
11/23/2005CN1228328C Pesticide intermediate compound
11/23/2005CN1228325C Biguanide derivatives
11/23/2005CN1228087C Medicinal preparation and its prepn. and application
11/23/2005CN1228054C Artificial skin powder prepn containing sodium hyaluronate and its prepn
11/23/2005CN1228053C Eye drop containing diuridine phosphoric acid
11/23/2005CN1228052C Total flavone for treating cadiovasular cerebrovasular system diseases, and preparing method and use thereof
11/23/2005CN1228051C Medicinal composition for treating cardiovascular disease
11/23/2005CN1228050C Medicine for preventing tissue from adhesion after operation
11/23/2005CN1228049C Slow releasing micropill containing active component of indapamide and method for preparing the same
11/23/2005CN1228048C Medicine composition containing alpha-pinene and 1,8-eucalyptol fever-tree oil and use thereof
11/23/2005CN1228047C Remedies for heratoconjunctival diseases containing farnesyl acetate as the active ingredient
11/23/2005CN1228046C Fluctin slow release tablet
11/23/2005CN1228044C Water-soluble medicine particle-type slow-release composition, preparation and its preparing method
11/23/2005CN1228043C Sustained release groundmass for highly soluble drugs
11/23/2005CN1228042C Asiaticoside liposome and its use
11/23/2005CN1228041C Methods for preparation of lipid-encapsulated therapeutic agents
11/23/2005CN1228039C Composition containing N-vinyl iminazole polymer or copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology
11/23/2005CN1227977C Composition of N-phenyl-N'-benzoyl carbamide derivant and stem protein compound for preventing vermin
11/22/2005US6968226 Method and system for terminating an atrial arrhythmia
11/22/2005US6967259 Process for the preparation of Citalopram intermediate
11/22/2005US6967248 Crystalline forms of meloxicam and processes for their preparation and interconversion
11/22/2005US6967245 Ucp5
11/22/2005US6967220 antibiotics; treating respiratory system disorders; n-hydroxy benzyl formamide derivatives
11/22/2005US6967219 Reversing or preventing premature vascular senescence
11/22/2005US6967218 Pravastatin pharmaceutical formulations and methods of their use
11/22/2005US6967216 Neuropeptide Y receptor modulators; treating eating disorders
11/22/2005US6967214 Inhibitors of IMPDH enzyme
11/22/2005US6967211 (E)-4-[2-{2-[N-acetyl-N-(4-methoxybenzenesulfonyl)amino]phenyl}ethenyl]pyridine 1-oxide; has an intense anticancer activity and very low toxicity
11/22/2005US6967210 Multiple sclerosis, brain disorders, analgesics
11/22/2005US6967208 Anticoagulants; cardiovascular disorders
11/22/2005US6967207 Preventive or therapeutic agents for gastric or esophageal regurgitation
11/22/2005US6967205 Compounds with antibacterial and antiparasitic properties
11/22/2005US6967204 Treatment of insulin resistance syndrome and type 2 diabetes with PDE9 inhibitors
11/22/2005US6967203 Use of pyridoindolone derivatives for preparing anticancer medicines
11/22/2005US6967201 Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists
11/22/2005US6967200 Remedies for cirrhosis
11/22/2005US6967199 Substituted diamine derivatives useful as motilin antagonists
11/22/2005US6967198 Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
11/22/2005US6967197 Also used in production of tumor necrosis factor alpha
11/22/2005US6967196 Sulfonamide compounds and uses thereof
11/22/2005US6967195 2-substituted ring A aromatic sterol derivatives having a comparatively short 17-position hydrocarbyl side chain terminates in an carboxaldehyde or hydroxy group; antiproliferative and antiangiogenic agent
11/22/2005US6967107 reacting with first one end and then the other of a polyoxyalkylene terminated on one end with a maleimidylarylaminocarbonyloxy group and on the other by a compound having a succinimidyloxycarbonyl group
11/22/2005US6967079 Pyrimidine derivatives for labeled binding partners
11/22/2005US6967034 Herbal-based composition for treating acute and chronic myeloid leukemia
11/22/2005US6967031 silymarin, salicin, at least one B vitamin, magnesium, molybdenum and manganese; for ingestion prior to, during, or after the consumption of the alcohol
11/22/2005US6967030 Formulation for insulin and glucose control
11/22/2005US6967023 solidifying agent consists of a long chain fatty alcohol having at least 15 carbon atoms in its backbone and a fatty acid having at least 18 carbons in its backbone; carrier is semi-solid at rest and liquefies upon application of shear forces
11/22/2005US6967022 Ganglioside-KLH conjugate vaccines plus QS-21
11/22/2005US6967020 Oxygen carrier system, artificial oxygen carrier, and reducing agent
11/22/2005US6967017 preservative-free mixture of water and propylene glycol; pH of 3.5 to 5.0 achieved by the addition of a concentrated strong acid; can be nebulised with currently available nebulisers
11/22/2005US6967002 Method and apparatus for producing a sterile fluid
11/22/2005US6966874 Concentric tubular centrifuge
11/22/2005CA2433181C Amlodipine hemifumarate
11/22/2005CA2378894C Taste masking of oral quinolone liquid preparations using ion exchange resins
11/22/2005CA2304722C Acidic addition salts of morphine alkaloids and the application thereof
11/22/2005CA2277100C Cyclic sulfone derivatives
11/22/2005CA2258918C Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
11/22/2005CA2252806C Polymorphs of donepezil hydrochloride and process for production
11/22/2005CA2249336C Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs
11/22/2005CA2184101C Carbapenem derivatives
11/22/2005CA2181553C Pyrrolopyridazine derivatives
11/22/2005CA2175547C Skin care compositions containing fatty acid amides and retinol or retinyl ester
11/22/2005CA2161683C Veterinary composition containing a proton pump inhibitor
11/22/2005CA2153348C Enteral diet and method for providing nutrition to a diabetic
11/22/2005CA2109697C Oral-administration forms of a medicament containing pantoprazole
11/22/2005CA2068066C Herpesvirus particles and vaccine
11/20/2005CA2467894A1 A composition for prevention and treatment of colon adenomas
11/19/2005CA2467715A1 Compositions and methods for inhibiting bone resorption
11/18/2005CA2472806A1 Compositions and methods for treating turf insect pests and diseases such as fungal infestations
11/17/2005WO2005108617A2 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
11/17/2005WO2005108575A1 T-type calcium channel splice variant compositions and methods
11/17/2005WO2005108572A1 Compounds and method for immunosuppression
11/17/2005WO2005108420A1 Cancer associated antigens
11/17/2005WO2005108414A1 Crystalline forms of 9-(s)-erythromycylamine
11/17/2005WO2005108413A1 Carbamate linked macrolides useful for the treatment of microbial infections
11/17/2005WO2005108412A1 Ester linked macrolides useful for the treatment of microbial infections
11/17/2005WO2005108403A2 Dealkylated derivatives of pyrrolo[2,1-b]benzothiazepines with atypical antipsychotic activity
11/17/2005WO2005108402A1 3,6-diazabicyclos[3.1.1]heptane derivatives with analgesic activity
1 ... 4462 4463 4464 4465 4466 4467 4468 4469 4470 4471 4472 4473 4474 4475 4476 4477 4478 4479 4480 4481 4482 ... 7860